login

Syringe laws and pharmacy regulations are structural constraints on HIV prevention in the US

AIDSPublished 1 June 2000
J. Taussig, Beth Weinstein, Scott Burris, T. Stephen Jones
Citations79
SJR quartileQ1
SJR score1.21
SNIP0.90

TL;DR

Increasing access to sterile syringes through pharmacies requires the repeal or modification of legal barriers and is an inexpensive HIV prevention intervention with the potential to substantially reduce HIV transmission.

Abstract

Increasing access to sterile syringes through pharmacies requires the repeal or modification of legal barriers. Pharmacy sale of syringes to IDUs is an inexpensive HIV prevention intervention with the potential to substantially reduce HIV transmission. Further studies are needed to document how changes to legal barriers can influence HIV prevention for IDUs.

Keywords

Medicine